Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital‐based screening

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer

• Publication date

  2005-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.21298PMID 16047344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide scanning for linkage in Finnish breast cancer families

  2004cited by this paper
• Genome-wide scanning for linkage in Finnish breast cancer families

  2004cited by this paper
• The Sassari Cancer Registry (1993-1997)

  2002cited by this paper
• Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

  2002cited by this paper
• Cancer Incidence in Five Continents – Vol VIII: Northern Ireland

  2002cited by this paper
• BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling.

  2002cited by this paper
• Cancer incidence in five continents. Volume VIII.

  2002cited by this paper
• Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

  2001cited by this paper
• Founder BRCA1 and BRCA2 mutations in early‐onset French Canadian breast cancer cases unselected for family history

  2001cited by this paper
• Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.

  2001cited by this paper
• Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.

  2001cited by this paper
• BRCA1 and BRCA2 have a limited role in familial prostate cancer.

  2000cited by this paper
• Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases

  2000cited by this paper
• Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.

  2000cited by this paper
• Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.

  2000cited by this paper
• Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.

  2000cited by this paper
• Frequency of BRCA1/BRCA2 mutations in a population‐based sample of young breast carcinoma cases

  2000cited by this paper
• Identification of a founder BRCA2 mutation in Sardinia

  2000cited by this paper
• The Breast Cancer Information Core: Database design, structure, and scope

  2000cited by this paper
• The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

  2000cited by this paper
• Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary

  2000cited by this paper
• BRCA 1/2 Gene Mutation Testing‐based Cancer Prevention and the Moral Concerns of Different Types of Patients

  1999cited by this paper
• Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients

  1999cited by this paper
• Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.

  1999cited by this paper
• BRCA1 and BRCA2: a small part of the puzzle.

  1999cited by this paper
• Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

  1999cited by this paper
• Cancer risks in BRCA2 mutation carriers.

  1999cited by this paper
• Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer.

  1999cited by this paper
• The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.

  1999cited by this paper
• Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

  1998cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Population-based study of risk of breast cancer in carriers of BRCA2 mutation.

  1998cited by this paper
• Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer.

  1997cited by this paper
• A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2

  1997cited by this paper
• Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.

  1997cited by this paper
• BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

  1997cited by this paper
• Prevalence of Recurring BRCA Mutations Among Ashkenazi Jewish Women with Breast Cancer

  1997cited by this paper
• A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.

  1997cited by this paper
• Population genetics of BRCA1 and BRCA2.

  1997cited by this paper
• Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.

  1997cited by this paper
• Study of a single BRCA2 mutation with high carrier frequency in a small population.

  1997cited by this paper
• Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.

  1997cited by this paper
• The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

  1997cited by this paper
• Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

  1996cited by this paper
• Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

  1996cited by this paper
• High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.

  1996cited by this paper
• The genetic attributable risk of breast and ovarian cancer

  1996cited by this paper
• A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

  1996cited by this paper
• Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

  1994cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• TNM Classification of Malignant Tumours

  1987cited by this paper

• Spectrum of Germline BRCA1 and BRCA2 Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of Rome

  2020cites this paper
• BRCA and PALB2 mutations in a cohort of male breast cancer with one bilateral case.

  2020cites this paper
• Epidemiology and Genetic Susceptibility of Breast and Ovarian Cancer in Sardinian Population

  2020cites this paper
• Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals.

  2017cites this paper
• BRCA1/2 germline missense mutations: a systematic review

  2017cites this paper
• Analysis of 6174delT Mutation in BRCA2 Gene by Mutagenically Separated PCR Among Libyan Patients with Breast Cancer

  2016cites this paper
• Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study

  2016cites this paper
• Analysis of 6174 delT Mutation in BRCA 2 Gene by Mutagenically Separated PCR Among Libyan Patients with Breast Cancer

  2016cites this paper
• Genome-wide association study of susceptibility loci for breast cancer in Sardinian population

  2015cites this paper
• Epidemiology of ovarian cancer in North Sardinia, Italy, during the period 1992-2010.

  2015cites this paper
• ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy

  2014cites this paper
• Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia

  2014cites this paper
• Breast cancer in Morocco: a literature review.

  2014cites this paper
• A Comprehensive Focus on Global Spectrum of BRCA1 and BRCA2 Mutations in Breast Cancer

  2013cites this paper
• Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia

  2012cites this paper
• Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases

  2011cites this paper
• Triple-negative breast cancers: an updated review on treatment options.

  2011cites this paper
• Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA 1 / BRCA 2 databases

  2011cites this paper
• Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• Founder BRCA 1 / 2 mutations in the Europe : implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia

  2009cites this paper
• Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy

  2009cites this paper
• A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population

  2009cites this paper
• Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations

  2008cites this paper
• High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland.

  2008cites this paper
• Origin and distribution of the BRCA2-8765delAG mutation in breast cancer

  2007cites this paper
• Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy.

  2007cites this paper
• Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

  2007cites this paper
• Identificação e Caracterização de Pacientes em Risco para Câncer de Mama Hereditário no Sul do Brasil

  2007cites this paper
• Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families

  2006cites this paper